Outlook Therapeutics annual gross margin
2025
Outlook Therapeutics Gross Margin Growth & History (OTLK)
Outlook Therapeutics's gross margin was 4.05% for fiscal 2025.
View full Outlook Therapeutics company overviewOutlook Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | 4.05% | — |
Outlook Therapeutics quarterly gross margin
Q3.25
Q2.26
Q3.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | −95.00% | −165.78 pp |
| Q2 2026 | 2026-03-31 | −17.18% | — |
| Q3 2025 | 2025-06-30 | 70.78% | — |
Outlook Therapeutics gross margin trends
The latest reported quarter, Q3 2026, shows −95.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outlook Therapeutics source filings ↗